Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
How to manage recurrences after surgery in CRSwNP patients in the biologic era: a narrative review.
De Corso E, Settimi S, Montuori C, Cantiani A, Corbò M, Di Bella GA, Sovardi F, Pagella F, Rigante M, Passali GC, Paludetti G, Galli J. De Corso E, et al. Among authors: di bella ga. Acta Otorhinolaryngol Ital. 2023 Apr;43(Suppl. 1):S3-S13. doi: 10.14639/0392-100X-suppl.1-43-2023-01. Acta Otorhinolaryngol Ital. 2023. PMID: 37698095 Free PMC article. Review.
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL).
De Corso E, Pasquini E, Trimarchi M, La Mantia I, Pagella F, Ottaviano G, Garzaro M, Pipolo C, Torretta S, Seccia V, Cantone E, Ciofalo A, Lucidi D, Fadda GL, Pafundi PC, Settimi S, Montuori C, Anastasi F, Pagliuca G, Ghidini A, Cavaliere C, Maffei M, Bussu F, Gallo S, Canevari FRM, Paludetti G, Galli J; Dupireal Italian Study Group. De Corso E, et al. Allergy. 2023 Oct;78(10):2669-2683. doi: 10.1111/all.15772. Epub 2023 May 26. Allergy. 2023. PMID: 37203259
Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A "Real-Life" Observational Study.
De Corso E, Mele DA, Rizzi A, Spanu C, Corbò M, Pisciottano S, Mastrapasqua RF, Baroni S, Porru DP, De Maio G, Rizzuti A, Di Bella GA, Ortolan A, Bonini M, Cefaloni F, Boccabella C, Lombardi F, Chini R, Caruso C, Panfili M, Galli J. De Corso E, et al. Among authors: di bella ga. J Pers Med. 2024 Sep 23;14(9):1014. doi: 10.3390/jpm14091014. J Pers Med. 2024. PMID: 39338268 Free PMC article.
Sinonasal Biomarkers Defining Type 2-High and Type 2-Low Inflammation in Chronic Rhinosinusitis with Nasal Polyps.
De Corso E, Baroni S, Settimi S, Onori ME, Mastrapasqua RF, Troiani E, Moretti G, Lucchetti D, Corbò M, Montuori C, Cantiani A, Porru DP, Lo Verde S, Di Bella GA, Caruso C, Galli J. De Corso E, et al. Among authors: di bella ga. J Pers Med. 2022 Jul 29;12(8):1251. doi: 10.3390/jpm12081251. J Pers Med. 2022. PMID: 36013200 Free PMC article.
Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A "Real-Life" Observational Study in the First Year of Treatment.
De Corso E, Settimi S, Montuori C, Corbò M, Passali GC, Porru DP, Lo Verde S, Spanu C, Penazzi D, Di Bella GA, Nucera E, Bonini M, Paludetti G, Galli J. De Corso E, et al. Among authors: di bella ga. J Clin Med. 2022 May 10;11(10):2684. doi: 10.3390/jcm11102684. J Clin Med. 2022. PMID: 35628815 Free PMC article.